ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Idaho » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Idaho

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PATRICK GORMAN M.D.

Cardiovascular Disease

14,521

$656K

1242
1119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $52

JAMES SMITH MD

Cardiovascular Disease

9,838

$678K

805
773 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 20%

$69
Average prescription price

Avg: $52

RONALD JENKINS MD

Cardiovascular Disease

8,968

$614K

667
575 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 20%

$68
Average prescription price

Avg: $52

PAUL GERLACH MD

Cardiovascular Disease

7,906

$437K

267
233 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $52

RONALD FRITZ DO

Cardiovascular Disease

7,631

$435K

531
474 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $52

KIM COFFMAN MD

Cardiovascular Disease

7,277

$304K

523
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$42
Average prescription price

Avg: $52

CARL HANSON MD

Cardiovascular Disease

7,021

$266K

582
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $52

REED HARRIS D.O.

Cardiovascular Disease

6,857

$203K

495
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 20%

$30
Average prescription price

Avg: $52

MURALI BATHINA MD

Cardiovascular Disease

6,183

$262K

651
568 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$42
Average prescription price

Avg: $52

WOLFGANG SPYRA MD

Cardiovascular Disease

5,743

$221K

494
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $52

JOHN CHAMBERS M.D.

Cardiovascular Disease

5,296

$227K

480
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $52

DAVID KEMP M.D.

Cardiovascular Disease

5,122

$194K

478
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $52

GRAHAM WETHERLEY M.D.

Cardiovascular Disease

5,111

$286K

465
425 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$56
Average prescription price

Avg: $52

JAMES FIELD MD

Cardiovascular Disease

4,889

$245K

488
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $52

DOUGLAS BLANK MD

Cardiovascular Disease

4,714

$216K

465
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $52

DANIEL BROWN M.D.

Cardiovascular Disease

4,656

$140K

408
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 20%

$30
Average prescription price

Avg: $52

DAVID HINCHMAN MD

Cardiovascular Disease

4,651

$362K

616
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 20%

$78
Average prescription price

Avg: $52

MICHAEL WHISENANT MD

Cardiovascular Disease

4,488

$197K

468
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $52

ROMEO PAVLIC MD

Cardiovascular Disease

4,360

$189K

374
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $52

STEFANIE FRY MD

Cardiovascular Disease

4,320

$209K

467
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$48
Average prescription price

Avg: $52

BENJAMIN CALL MD

Cardiovascular Disease

4,285

$237K

455
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $52

DENNIS COOKE MD

Cardiovascular Disease

4,138

$250K

406
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 20%

$60
Average prescription price

Avg: $52

ANDREW CHAI MD

Cardiovascular Disease

4,038

$237K

484
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$59
Average prescription price

Avg: $52

DENNIS ENOMOTO MD

Cardiovascular Disease

3,968

$168K

364
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 20%

$42
Average prescription price

Avg: $52

ALFRED NARRAWAY DO

Cardiovascular Disease

3,819

$182K

457
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$48
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank